Issue link: https://nebusinessmedia.uberflip.com/i/1509493
36 HARTFORDBUSINESS.COM | OCTOBER 16, 2023 POWER 25 | HEALTH CARE Mark Meador F armington health insurer ConnectiCare named a new leader in June. The company, owned by New York-based EmblemHealth, picked Mark Meador as its next president. Meador oversees the health plan's business in Connecticut and Massachusetts. He's been with ConnectiCare since 2019, previously serving as the company's general counsel. Before that, he spent over 20 years with Aetna in various executive positions. Earlier in his career, he held lead- ership positions with other insurance carriers, including Prudential, and worked for a private law firm in Atlanta, Georgia. Meador holds a bachelor's degree in economics from Emory Univer- sity and is a graduate of the Emory University School of Law. He has taken over at a time of change for ConnectiCare, which announced last year it was with- drawing from the state's fully insured, small group market. The company said it made the decision because it could "no longer offer competitively priced fully insured small employer products in this market." The company still sells individual, large employer, fixed-funding and Medicare Advantage plans in Connecticut. Bill Moschella B ill Moschella is a serial entre- preneur who has found a niche in the healthcare data analytics space. In August, he announced that his latest startup, Farmington-based Populi, was acquired by Definitive Healthcare of Massachusetts for $52 million. Populi offers healthcare data analytics as a subscription service. The technology monitors millions of medical prac- titioners and healthcare organiza- tions, capturing various data points, including referrals, procedures, costs, outcomes, etc. It uses that data and AI to iden- tify procedure trends and new market opportunities for clients, including hospitals. Populi was Moschella's seventh startup. He's perhaps best known for Evariant, a healthcare consumer and physician engagement tech company that raised $100 million in venture capital, before it was acquired by Healthgrades (now Mercury Healthcare). He currently serves as executive chairman of Stemify, an online learning platform that tests students' math skills, uses artificial intelligence to identify knowledge gaps and creates an individualized curriculum using a cache of videos and tutorials. He's also managing director of Masheen, a family-owned venture investment firm, with a focus on Connecticut startups. Krishnan Nandabalan K rishnan Nandabalan is president and CEO of Guil- ford-based InveniAI, which uses artificial intelligence to discover and develop new drugs. The company is pursuing potential treatments for ailments such as irritable bowel syndrome, inflammatory bowel disease and more. For more than a decade, Nandabalan has applied AI, big data analytics and machine learning in the healthcare field. Earlier this year, InveniAI launched a new tool that incor- porates GPT-4 by OpenAI, the artificial intelligence behind the ChatGPT chatbot. The tool, called ChatAlphaMeld, is designed to give answers and insights for drug and target discovery. InveniAI's AlphaMeld highlights associations between genes, targets, pathways, biomarkers, drugs, diseases and symptoms. Its database includes information on 49,000 drugs, 20,000 genes, 30,000 disease and symptoms, 73,000 expression datasets, and 1,400 cell types, for example. Nandabalan led the 2017 spinout of BioXcel Therapeutics and Inve- niAI from parent company BioXcel LLC. While InveniAI is focused on artificial intelligence applications for drug discovery, its sister company, BioXcel Therapeutics, is focused on neuroscience. BioXcel's clinical stage subsid- Level Funded health plans are catching on Don't miss out on up to 17% potential savings for your small business 1 In 2019, only 7% of small businesses offered a level funded health plan. Today, more than a third of them do. 2 Get in on Oxford Level Funded and the advantages that come with it — like exemption from many ACA regulations and surplus refund potential, 3 too. Talk to your broker today 1 Average savings for UnitedHealthcare and Oxford Fully Insured groups 2–50 nationwide migrated to UnitedHealthcare and Oxford Level Funded, Jan. 1, 2021–Dec. 31, 2022. Savings are not guaranteed. 2 Kaiser Family Foundation Employer Health Benefits Surveys, 2019 and 2022. For the purposes of the surveys, a "small business" was defined as groups with 3-199 employees. 2019 survey available: https://www.kff.org/report-section/ehbs- 2019-section-10-plan-funding/. 2022 survey available: https://www.kff.org/report-section/ehbs-2022-section-10-plan- funding/. Accessed: Feb. 17, 2023. 3 Please consult a tax and/or legal advisor to determine if, by receiving this refund, there are any restrictions or obligations. Surplus refund available only where allowed by law. Administrative services provided by Oxford Health Plans LLC. Stop-loss insurance is underwritten by UnitedHealthcare Insurance Company or their affiliates, including UnitedHealthcare Life Insurance Company in NJ and UnitedHealthcare Insurance Company of New York in NY. B2B EI232496973-OXF 8/23 © 2023 Oxford Health Plans LLC All Rights Reserved. 23-2497419-T